List of Dassault Biovia Customers
Dassault Systemes
10 rue Marcel Dassault,
Velizy-Villacoublay, 78140,
France
Velizy-Villacoublay, 78140,
France
33 1 61 62 61 62
Professional Services
25967
$7.2B
Since 2010, our global team of researchers has been studying Dassault Biovia customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Dassault Biovia for Laboratory Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Dassault Biovia for Laboratory Management include: Johnson & Johnson, a United States based Life Sciences organisation with 138100 employees and revenues of $88.82 billion, Roche, a Switzerland based Life Sciences organisation with 112774 employees and revenues of $80.28 billion, Eli Lilly, a United States based Life Sciences organisation with 50605 employees and revenues of $65.18 billion, Pfizer, a United States based Life Sciences organisation with 81000 employees and revenues of $63.63 billion, Sanofi, a France based Life Sciences organisation with 82878 employees and revenues of $47.74 billion and many others.
Contact us if you need a completed and verified list of companies using Dassault Biovia, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Dassault Biovia customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Altria | Consumer Packaged Goods | 6200 | $24.0B | United States | Dassault Systemes | Dassault Biovia | Laboratory Management | 2020 | n/a |
In 2020, Altria implemented Dassault Biovia for Laboratory Management. The deployment used the BIOVIA ONE Lab platform to deliver a regional LIMS and electronic laboratory notebook manufacturing solution, and was executed to replace LabWare LIMS.
Configuration work centered on LIMS and ELN modules, including sample lifecycle management, test data capture, workflow orchestration for laboratory procedures, and manufacturing sample management. The Dassault Biovia implementation included configuration of data models, templates, and workflow automation consistent with Laboratory Management functional patterns.
The solution was hosted on a private Azure cloud, establishing a cloud hosted architecture for BIOVIA ONE Lab and centralized laboratory data stores. Implementation was delivered by an Agile Product Team under a multi year contract through Apex Systems, with a LIMS Business Analyst embedded in the team in Houston Texas to align lab requirements with system configuration. Operational scope covered regional manufacturing laboratories and laboratory operations supporting production workflows.
Governance used agile release sprints, product backlog management, and role based configuration control to coordinate build and validation activities. The engagement window ran from October 2020 to May 2022, with iterative releases driven by analyst defined acceptance criteria and user stories for lab workflows.
|
 |
Amgen | Life Sciences | 28000 | $33.4B | United States | Dassault Systemes | Dassault Biovia | Laboratory Management | 2023 | n/a |
In 2023, Amgen deployed Dassault Biovia as its Laboratory Management platform to support Attribute Science Digital and the Pivotal Portfolio. The implementation is framed to centralize lab informatics capabilities for experiment capture, electronic laboratory notebook workflows, and end to end data integration across analytical science functions.
Dassault Biovia was configured to support ELN workflows and experiment lifecycle management, with explicit emphasis on electronic lab notebook capabilities such as Biovia One Lab, automation of qualification scripts, and metadata management via reference ontology. The configuration includes instrumentation and chromatography data ingestion patterns consistent with laboratory data capture, and pipeline handoffs to analytics tooling for downstream processing.
Integrations documented for the program include connections with chromatography data systems, reference ontology services, analytics platforms DataBricks and Spotfire, and exploratory use of generative AI technologies for lab informatics augmentation. Operational coverage is centered on Attribute Science, the ELN product team, and partner functions that perform testing, troubleshooting, and end user support within lab operations and analytical development.
Governance and delivery use Agile methodologies driven by the ELN product team, with structured testing of workflows, execution of qualification scripts, and runbook style support for scientists. The rollout emphasizes product team ownership of configuration, close collaboration with data science for analytics handoffs, and formalized processes for end to end data integration and ongoing lab informatics optimization.
|
 |
Arcolab | Life Sciences | 800 | $100M | India | Dassault Systemes | Dassault Biovia | Laboratory Management | 2019 | n/a |
In 2019, Arcolab implemented Dassault Biovia as its Laboratory Management platform. The deployment centered on the Biovia One Lab application to support laboratory execution, methods management and quality workflows at Arcolab's Bengaluru site.
Configuration and functional work emphasized LIMS eRDS controls and worksheet lifecycle management. Implementation activities included establishing controls in LIMS eRDS to meet quality team expectations, migrating worksheets from development to quality environments, and assigning input logics for RPA worksheets to enable automated data capture and standardized execution. Technical administration and compliance work for the Biovia One Lab application covered site specific Laboratory Execution Procedure and Methods Management creation and updates.
Operational governance included review, evaluation, impact assessment and rectification of eRDS data errors, with coordinated follow up across business units for completion of eRDS records. The project used segregated development and quality environments to manage validation artifacts and controlled migrations, aligning with laboratory validation and release practices.
A dedicated LIMS Developer and Validation role managed technical administration of Dassault Biovia and coordinated with quality and BU teams to enforce governance, perform validations and remediate data issues. The Arcolab Dassault Biovia Laboratory Management implementation therefore supported lab operations and quality functions through procedural controls, automated worksheet logic and controlled environment migrations.
|
 |
AstraZeneca India | Life Sciences | 935 | $207M | India | Dassault Systemes | Dassault Biovia | Laboratory Management | 2023 | n/a |
In 2023, AstraZeneca India implemented Dassault Biovia as a Laboratory Management application to support Alexion AstraZeneca Rare Disease quality and analytical operations in Bengaluru, aligning the platform with Quality and Manufacturing Science and Analytical Technology functions. The deployment emphasized lab execution and regulated data capture across on-site laboratory operations and supporting IT validation processes.
The implementation centered on Dassault Biovia platform capabilities, with explicit use of Biovia ONE Lab LES for laboratory execution, protocol orchestration, and structured experimental data capture. Configuration work included LES workflow modeling, sample and test lifecycle control, and automation-ready interfaces for instrument data ingestion and result reconciliation.
Integrations and operational coverage were scoped to interoperate with chromatography data systems and document and quality systems referenced by the organization, including Empower 3 CDS for instrument-level chromatography data, Veeva Vault QualityDocs for controlled documentation, Veeva Vault QMS for quality workflows, ValGenesis or Kneat Gx for validation lifecycle management, and Waters NuGenesis SDMS for scientific data storage. The integration footprint targeted Quality, MSAT, and laboratory operations teams, enabling coordinated handoffs between lab execution, data archival, and quality governance processes.
Governance and rollout emphasized GxP-aligned IT validation and risk assessment methodologies, using GAMP 5 principles and ITIL-informed service practices to manage BAU support, upgrades, and change control. Validation lifecycle coordination reflected requirements for cloud-based system validation and automated testing frameworks, supporting continuous validation approaches and instrument qualification activities where applicable.
|
 |
Eli Lilly | Life Sciences | 50605 | $65.2B | United States | Dassault Systemes | Dassault Biovia | Laboratory Management | 2022 | n/a |
In 2022 Eli Lilly implemented Dassault Biovia as a Laboratory Management platform to standardize laboratory data capture and experiment workflows within its bioanalytical chemistry and molecular pharmacology groups. The deployment focused on core laboratory needs, positioning Dassault Biovia to support electronic laboratory notebook capture, sample and inventory management, and workflow orchestration for assay development in regulated bioanalysis environments.
The implementation configured Dassault Biovia modules aligned with Laboratory Management best practices, including electronic laboratory notebook functionality, sample lifecycle and chain of custody tracking, and laboratory workflow automation to support assay setup, calibration, and result review. Configuration emphasized data review and reporting capabilities to align with internal quality controls and FDA guidance for bioanalytical assay development.
Integrations were implemented with laboratory instrumentation and vendor analysis suites used by Eli Lilly bioanalytical teams, including liquid chromatography and mass spectrometry platforms and software such as MultiQuant, Analyst, MassHunter, Sciex OS, and Signals. The Dassault Biovia deployment was also connected to the electronic lab notebook capture used by bench scientists, supporting data consolidation from Shimadzu systems, Sciex QTRAP 6400 and Triple Quad 5500 and 6500, Agilent RapidFire, Sciex Echo, and automation platforms such as Hamilton Nimbus.
Governance and operational controls were structured to support validated workflows, routine equipment calibration, sample handling protocols, and assay documentation consistent with FDA-aligned practices. Operational ownership landed with bioanalytical and quantitative biology teams, and the Dassault Biovia Laboratory Management implementation reinforced standardized processes for data review, instrument troubleshooting records, and safety and calibration oversight in onsite laboratory operations.
|
 |
|
Life Sciences | 1000 | $100M | United States | Dassault Systemes | Dassault Biovia | Laboratory Management | 2024 | n/a |
|
|
|
|
Life Sciences | 10 | $1M | Canada | Dassault Systemes | Dassault Biovia | Laboratory Management | 2023 | n/a |
|
|
|
|
Life Sciences | 17600 | $28.8B | United States | Dassault Systemes | Dassault Biovia | Laboratory Management | 2020 | n/a |
|
|
|
|
Life Sciences | 16167 | $750M | India | Dassault Systemes | Dassault Biovia | Laboratory Management | 2020 | n/a |
|
|
|
|
Life Sciences | 138100 | $88.8B | United States | Dassault Systemes | Dassault Biovia | Laboratory Management | 2023 | n/a |
|
Showing 1 to 10 of 18 entries
Buyer Intent: Companies Evaluating Dassault Biovia
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Dassault Biovia. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating Dassault Biovia for Laboratory Management include:
- JPMorgan Chase, a United States based Banking and Financial Services organization with 317233 Employees
- Hokusei Industry, a Japan based Distribution company with 25 Employees
- Studio Graphene, a United Kingdom based Professional Services organization with 10 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||
FAQ - APPS RUN THE WORLD Dassault Biovia Coverage
Dassault Biovia is a Laboratory Management solution from Dassault Systemes.
Companies worldwide use Dassault Biovia, from small firms to large enterprises across 21+ industries.
Organizations such as Johnson & Johnson, Roche, Eli Lilly, Pfizer and Sanofi are recorded users of
Dassault Biovia for Laboratory Management.
Companies using Dassault Biovia are most concentrated in Life Sciences, with adoption spanning over 21 industries.
Companies using Dassault Biovia are most concentrated in United States, Switzerland and France, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Dassault Biovia across Americas, EMEA, and APAC.
Companies using Dassault Biovia range from small businesses with 0-100 employees - 5.56%, to mid-sized firms with 101-1,000 employees - 38.89%, large organizations with 1,001-10,000 employees - 11.11%, and global enterprises with 10,000+ employees - 44.44%.
Customers of Dassault Biovia include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified Dassault Biovia customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Laboratory Management.